First Quadrant’s Jazz Pharmaceuticals JAZZ Stock Holding History

First Quadrant’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-141	Closed	-$23K	–	591
2020 Q4	$23K	Buy	+141	New	+$21K	﹤0.01%	506
2020 Q3	–	Sell	-2,124	Closed	-$234K	–	665
2020 Q2	$234K	Sell	2,124 -1,700	-44%	-$188K	0.03%	400
2020 Q1	$381K	Sell	3,824 -5,799	-60%	-$750K	0.06%	309
2019 Q4	$1.44M	Hold	9,623	–	–	0.12%	172
2019 Q3	$1.23M	Buy	9,623 +900	+10%	+$121K	0.12%	187
2019 Q2	$1.24M	Hold	8,723	–	–	0.09%	262
2019 Q1	$1.25M	Buy	+8,723	New	+$1.14M	0.1%	220
2017 Q2	–	Sell	-62,038	Closed	-$9M	–	917
2017 Q1	$9M	Hold	62,038	–	–	0.18%	187
2016 Q4	$6.76M	Hold	62,038	–	–	0.14%	211
2016 Q3	$7.54M	Sell	62,038 -6,385	-9%	-$861K	0.16%	191
2016 Q2	$9.67M	Buy	68,423 +67,800	+10,883%	+$9.99M	0.21%	160
2016 Q1	$81K	Hold	623	–	–	﹤0.01%	654
2015 Q4	$88K	Sell	623 -600	-49%	-$83.1K	﹤0.01%	627
2015 Q3	$162K	Hold	1,223	–	–	﹤0.01%	565
2015 Q2	$215K	Sell	1,223 -27	-2%	-$4.85K	﹤0.01%	554
2015 Q1	$216K	Sell	1,250 -2,615	-68%	-$449K	﹤0.01%	526
2014 Q4	$633K	Sell	3,865 -100	-3%	-$16.6K	0.01%	417
2014 Q3	$637K	Sell	3,965 -96	-2%	-$14.8K	0.01%	430
2014 Q2	$597K	Sell	4,061 -28,200	-87%	-$3.91M	0.01%	457
2014 Q1	$4.47M	Sell	32,261 -30,264	-48%	-$4.56M	0.1%	204
2013 Q4	$7.91M	Buy	62,525 +57,600	+1,170%	+$5.96M	0.19%	149
2013 Q3	$453K	Sell	4,925 -600	-11%	-$48.4K	0.01%	467
2013 Q2	$380K	Buy	+5,525	New	+$338K	0.01%	470

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

First Quadrant's JAZZ Position: Q1 2021 in Review

First Quadrant sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2021, closing a stake of 141 shares — an estimated $23K sold.

First Quadrant first reported a position in JAZZ in Q2 2013 and held it in 23 quarters. The position peaked at $9.67M in Q2 2016. 441 funds tracked by Wall St. Rank hold JAZZ as of Q1 2021.

First Quadrant reported no remaining Jazz Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
First Quadrant sold 141 Jazz Pharmaceuticals shares in Q1 2021, an estimated $23K.
First Quadrant first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 23 quarters.
First Quadrant's Jazz Pharmaceuticals position peaked at $9.67M in Q2 2016.
441 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2021.

Based on First Quadrant's 13F filing for Q1 2021, filed 27 Apr 2021.